Report Summary
Eternity Insights has published a new study on Global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market focusing on key segments as by Type (Glycerin, Propylene Glycol, Sorbitol, Mannitol, Others), by Application (Industrial Application, Non-industrial Application, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market Segmentation:
Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market, By Type
- Glycerin
- Propylene Glycol
- Sorbitol
- Mannitol
- Others
Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market, By Application
- Industrial Application
- Non-industrial Application
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Oral Solid Dosage Forms (OSDF) And Pharma Excipients market in terms of demand generation. The Oral Solid Dosage Forms (OSDF) And Pharma Excipients market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Oral Solid Dosage Forms (OSDF) And Pharma Excipients market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market Taxonomy:
To learn more about this report
Global Oral Solid Dosage Forms (OSDF) And Pharma Excipients Market Competitive Landscape
The global Oral Solid Dosage Forms (OSDF) And Pharma Excipients market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- ABITEC Corporation
- AkzoNobel
- Archer Daniels Midland (ADM)
- BASF
- DOW Chemical Company
- Evonik
- J.M. Huber Corporation
- Cargill
- Eastman Chemical Company
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Glycerin, Propylene Glycol, Sorbitol, Mannitol, Others |
| By Application Outlook |
Industrial Application, Non-industrial Application, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, DOW Chemical Company, Evonik, J.M. Huber Corporation, Cargill, Eastman Chemical Company |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report 2021-2027, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type
1.4.2 Glycerin
1.4.3 Propylene Glycol
1.4.4 Sorbitol
1.4.5 Mannitol
1.4.6 Others
1.5 Market by Application
1.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application
1.5.2 Industrial Application
1.5.3 Non-industrial Application
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
2.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2017-2027
2.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production 2017-2027
2.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Capacity 2017-2027
2.1.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Marketing Pricing and Trends
2.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Growth Rate (CAGR) 2021-2027
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
3.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Manufacturers
3.1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Manufacturers
3.1.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Manufacturers
3.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers
3.2.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2017-2020)
3.2.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2017-2020)
3.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Regions
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production by Regions
4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Market Share by Regions
4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Regions
4.2 United States
4.2.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
4.2.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue
4.2.3 Key Players in United States
4.2.4 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Import & Export
4.3 Europe
4.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
4.3.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Import & Export
4.4 China
4.4.1 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
4.4.2 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue
4.4.3 Key Players in China
4.4.4 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Import & Export
4.5 Japan
4.5.1 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production
4.5.2 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Import & Export
4.6 Other Regions
4.6.1 South Korea
4.6.2 India
4.6.3 Southeast Asia
5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Regions
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Regions
5.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Regions
5.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Regions
5.2 North America
5.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
5.2.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
5.3.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
5.4.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
5.5.2 Central & South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
5.6.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa
6 Market Size by Type
6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Breakdown Dada by Type
6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type
6.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Breakdown Dada by Application
7.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption by Application
7.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Market Share by Application (2017-2020)
8 Manufacturers Profiles
8.1 ABITEC Corporation
8.1.1 ABITEC Corporation Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.1.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.1.5 SWOT Analysis
8.2 AkzoNobel
8.2.1 AkzoNobel Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.2.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.2.5 SWOT Analysis
8.3 Archer Daniels Midland (ADM)
8.3.1 Archer Daniels Midland (ADM) Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.3.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.3.5 SWOT Analysis
8.4 BASF
8.4.1 BASF Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.4.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.4.5 SWOT Analysis
8.5 DOW Chemical Company
8.5.1 DOW Chemical Company Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.5.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.5.5 SWOT Analysis
8.6 Evonik
8.6.1 Evonik Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.6.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.6.5 SWOT Analysis
8.7 J.M. Huber Corporation
8.7.1 J.M. Huber Corporation Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.7.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.7.5 SWOT Analysis
8.8 Cargill
8.8.1 Cargill Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.8.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.8.5 SWOT Analysis
8.9 Eastman Chemical Company
8.9.1 Eastman Chemical Company Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
8.9.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Description
8.9.5 SWOT Analysis
9 Production Forecasts
9.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production and Revenue Forecast
9.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Forecast 2021-2027
9.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast 2021-2027
9.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production and Revenue Forecast by Regions
9.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Regions
9.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Forecast by Regions
9.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Forecast by Type
9.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Countries 2021-2027
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Countries 2021-2027
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Countries 2021-2027
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Country 2021-2027
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumption Forecast by Countries 2021-2027
10.7.2 Middle East and Africa
10.7.3 Turkey
10.7.4 GCC Countries
10.7.5 Egypt
10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients Upstream Market
11.1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Key Raw Material
11.1.2 Typical Suppliers of Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Raw Material
11.1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Raw Material Market Concentration Rate
11.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors
11.5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
